May/June 2013

Editor's Page

Allen C. Ho, MD, and Robert L. Avery, MD

Virtual Game Improves Navigation Skills in Blind Patients

Callan Navitsky, Senior Editor

2013 Macula Society Musings

Nikolas London, MD

The Physician Payment Sunshine Act: An Update

What physicians and industry should know about the final rule.

Allison Weber Shuren, MSN, JD

If I Could Do It All Over Again

Experienced retina specialists recall transitioning from trainee to attending.

Francis Char DeCroos, MD; Rajiv E. Shah, MD; and Adam T. Gerstenblith, MD; With Sunir J. Garg, MD; Andre J. Witkin, MD; and Omesh P. Gupta, MD, MBA

Logistics of Performing Clinical Research

Michael J. Koss, MD, FEBO, With Michele Formoso

Combined Phaco-vitrectomy

Advantages include the elimination of a second procedure and improved access to the retinal periphery.

Claus Eckardt, MD

Common Questions Regarding the Safety of Ocriplasmin

Jorge A. Fortun, MD, and Rohit Ross Lakhanpal, MD

Treatment for Diabetic Macular Edema in Japan

Toshinori Murata, MD, PhD

Coats Disease with Gliotic Nodule Simulating Retinoblastoma

A'sha Brown, BS; Swathi Kaliki, MD; and Carol L. Shields, MD

Developments in Therapy for Neovascular AMD

Treatments on the horizon move beyond the paradigm of monthly anti-VEGF therapy.

Pravin U. Dugel, MD

Quantifying Drusen in AMD

An interview with Duncan Friedman, MD, MPH; and Christine A. Curcio, PhD

Duncan Friedman, MD, MPH, and Christine A. Curcio, PhD

Use of Viral Vectors in the Treatment of Retinal Disease

Early-phase clinical trials of several gene therapy entities are under way.

Andreas K. Lauer, MD

Anti-PDGF Combination Therapy for AMD

Results of a phase 2 study.

Richard S. Kaiser, MD

Suprachoroidal Buckling Technique

A novel, less-invasive treatment option for rhegmatogenous retinal detachment and vitreoretinal interface pathologies.

Yusuke Oshima, MD; Ehab N. El Rayes, MD; Nagakazu Matsumura, MD; and Hirokazu Sakaguchi, MD

Polypoidal Choroidal Vasculopathy: Perspective from Noninvasive Retinal Imaging

Clinical differentiation between PCV and typical neovascular AMD is important, as these 2 diseases differ in natural course and response to treatment.

Hideki Koizumi, MD, PhD

5Q With Virgilio Morales-Canton, MD